Louis Plamondon

Louis Plamondon, Ph.D., currently serves as Executive Vice President and Head of Pharmaceutical Development at TRIANA Biomedicines since October 2024. Prior to this role, Plamondon held several prominent positions at LifeMine Therapeutics, Constellation, Vertex Pharmaceuticals, Karyopharm Therapeutics Inc., Tetraphase Pharmaceuticals, and Millennium Pharmaceuticals, where responsibilities included leading CMC activities, managing drug development processes, and overseeing teams in chemistry and pharmaceutical sciences. With a strong track record in developing small molecule drugs and substantial experience in cGMP manufacturing, Plamondon has contributed to significant advancements in oncology and microbiology. Educational qualifications include a Ph.D. in Organic Chemistry from Université de Montréal and postdoctoral research at Harvard University.